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Summary: We compare 4 statistical models for the establishment of assigned values in a control serum which are
based on the assumption of a normal distribution. The first model results in ± 2s, whereas each of the following
3 models are based on a special analysis of variance. We studied by means of appropriate statistical tests the distrib-
utional properties of the data of the study described in part 1 of this series (Passing, H. et al. (1981) this j. 19,
1137-1144).
Many model assumptions are violated: The totality of data of each method was never normally distributed, normal
distribution within laboratories was not given in 27 out of 67 cases, and precision and accuracy varied from refer-
ence laboratory to reference laboratory. Moreover, assigned values and uncertainty intervals calculated by means of
these methods can be misleading to the customer. Therefore, these models cannot be applied, and a distribution-free
procedure has to be used instead.
Die Unangemessenheit von Normalverteilungsmodellen bei der Ermittlung von Sollwerten in Kontrollseren
Ermittlung von Sollwerten in Kontrollseren, II
Zusammenfassung: Wir vergleichen 4 statistische Modelle zur Ermittlung von Sollwerten in einem Kontrollserum, die
auf der Annahme einer Normalverteilung basieren. Das erste Modell fuhrt zu ± 2s, während die folgenden drei
Modelle jeweils auf einer speziellen Varianzanalyse beruhen. Mit Hilfe geeigneter statistischer Tests untersuchten wir
die Verteilungseigenschaften der Daten der in Teil l dieser Reihe (Passing, H. et al. (1981) this j. 79, 1137-1144)
beschriebenen Studie.
Viele Modellannahmen sind verletzt: Die Gesamtheit der Daten jeder Methode war niemals normalverteilt, in 27 von
67 Fällen war keine Normalverteilung innerhalb der Laboratorien gegeben, und Präzision und Richtigkeit variierten
von Referenzläbor zu Refererizlabor. Außerdem können Sollwerte und Sollbereiche, die nach diesen Methoden be-
rechnet werden, für den Anwender irreführend sein. Deshalb können diese Modelle nicht angewandt werden, und an
ihrer Stelle muß ein verteilungsfreies Verfahren benutzt werden.
Introduction even when making the assumption). The consequences
of its violation are usually not known even though they
Various models for the establishment of assigned values
 may be ^ .^  Converselyj it is possible to define pro-
and their uncertainty intervals in a control serum are ^^
 which Qfe not based Qn such assumptions (3)
known from the literature (3,4, 5). They can be dis-
 $Q that they afe applicable more generally,
criminated according to the following two points of
view. In this paper we point out the mathematical assump-
First. Some models (4, 5) postulate that the analytical tions of four different ™<?dels> and we examine bv ™™
values have certain special distributional properties. of appropriate statistical tests whether they are justified
Such an assumption is then made ä priori and will in . ™«» "« »« able to assess the Applicability of the models
general not be checked again (probably it is not checked I m 1: c> (4> 5'·
Secondly. There are two different philosophies con-
>) A preliminary report is given in 1. c. (« cerning the meaning of an uncertainty interval. In 1. c.
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(5) it is, mathematically speaking, a confidence interval
i. e. it is very likely that the correct value of the control
serum due to the method applied will be within this
interval. Therefore, the width of the interval is a measure
of the precision of the computed assigned value and not
of single analytical values. In I.e. (3,4), however, the un-
certainty intervals are prediction intervals i. e. it is very
likely that one additional analytical value established by
the same method will be within it if systematical devia-
tions do not occur.
Since assigned values of control sera and their uncer-
tainty intervals are used for the internal quality control,
i.e. for monitoring analytical values, it is clear that
prediction intervals are more appropriate for this pur-
pose than confidence intervals. We therefore confine
ourselves to prediction intervals.
Materials and Methods
We used the data of the study performed by laboratories of
members of the Verband der Diagnostica- und Diagnostica-
ger te-Hersteller (VDGH, Association of Diagnostics and Dia-
gnostics Instrumentation Manufacturers) as described in I.e. (2).
Briefly, it was based on the constituents creatinine, glucose, urea,
alanine and aspartate aminotransferase2), creatine kinase2), and
7-glutamyltransferase2). For each constituent we had 9 to 11
laboratories (see I.e. (2) or table 4 below) each having performed
double determinations in approximately 18 independent series
of the unknown sample, of the known control, and of a blind
control, respectively.
Two cases were discriminated generally:
Case 1
Both values of the double determinations of the unknown
sample were used. They were accepted as valid in a series if
both values of the known control as well as both values of the
blind control of this series were within the uncertainty limits of
the respective assigned values given by the manufacturer(s), cf.
I.e. (2). In all other cases the whole series was eliminated.
Case 2
The first values only of the double determinations of the un-
known sample were used simulating single determinations, cf.
I.e. (2). They were accepted as valid in a series if the first value
of the known control as well as the first value of the blind con-
trol of this series were within the uncertainty limits of the
respective assigned value. In all other cases the whole series was
eliminated.
We considered the following statistical models for the unknown
sample, for details thereof see I.e. (6).
2) Enzymes:
Glutamate-pyruvate-transaminase = alanine aminotr ns-
ferase = X-alanine: 2-oxoglutarate aminotransferase
EC 2.6.1.2;
glutamate-oxalacetate-transaminase = aspartate aminotrans-
ferase = Æ,-aspartate: 2-oxoglutarate aminotransferase
EC 2.6.1.1;
T-glutamyl-transferase = (5-glutamyl)-peptide: aminoacid
5-glutamyltransferase EC 2.3.2.2;
creatine kinase = ATP: creatine N-phosphqtransferase
EC 2.7.3.2.
Model 1
The model equation for the analytical values is
where k runs over all available values, ì is the general mean.
The first assumption (Ai) concerns the errors ek.
(Áé): all ek come from one common normal distribution,
which implies equal accuracy. Furthermore, (Aj) implies that the
variance of the ek is the same for all laboratories, namely ó2,
which means equal precision within laboratories.
Moreover, all analytical values must be independent.
Model 2
The model equation for the analytical values is
where i enumerates the laboratories and k all valid values
within the i-th laboratory, ì is the general mean. lj is the devia^
tiori of the i-th laboratory from ì thus permitting various accu-
racy within laboratories, assumed as a fixed effect. Regarding
the errors eik it is assumed that
the ejk of all laboratories come from one common normal
distribution,
): the variance of the ejk is the same for all laboratories,
namely ó2, which means equal precision within laboratories.
All analytical values must be independent.
This model is contained in I.e. (4). It should be stressed that in
1. c. (5) the same assumptions must be made, though both
models are quite different.
Model 3
The model equation for the analytical values is
xik j + eik
where i, k, and ì have the same meaning as in model 2. Lj is
the deviation of the i-th laboratory from ì, as a random effect.
This means that the laboratories included are considered as
random samples out of a population. It is assumed that
(A4): all Lj come from a normal distribution with variance ó£.
The assumption concerning the errors 6jk is that
(As): the e;k of all laboratories come from one common nor1
mal distribution.
This implies that
(A5'): the variance of the eik is the same for all laboratories,
namely ó2, which means equal precision within laboratories.
Additionally, the Lj and the ejk are all assumed to be independ-
ent so that the Variance of the analytical values is ó| = ó£ + ó2.
This model is also contained in 1. c. (4).
Models 1 to 3 need not be modified, no matter if case 1 or case 2
occurs, but we must modify model 4. Additionally it is necessary
with model 4 to restrict ourselves to a fixed number of valid
series in common to all laboratories, i.e. to have a balanced
design.
Model 4.1
The model equation for the analytical values is
where i enumerates the laboratories,] the series within each
laboratory and k the two values of the double determination.
ì is again the general mean. Lj is the random deviation of the
i-th laboratory from ì. The laboratories included are again con-
sidered as random samples out of a population. It is assumed
that
(A6): all Lj come from a normal distribution with variance Ü£
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Analogously, Sj is the random deviation of the j-th series from
ì. The series performed are considered as random samples out
of a population. It is assumed that
(A7): all Sj come from a normal distribution with variance ó|.
As to the random interaction term (LS)jj it is assumed that
(As): all (LS)jj come from a common normal distribution with
variance ó£§.
Moreover, concerning the analytical errors eijk, it is postulated
that
(A9): the ejjk of all laboratories and all series come from one
common normal distribution.
This implies that
(A9'): the variance of e^ is the same for all laboratories,
namely ó|, which means equal precision within series for all
laboratories.
Finally, the Lj, Sj, (LS)jj, and ejjk must all be mutually in-
dependent so that the variance of the analytical values is
2 _ 2 . 2
**4 1 ~~ ^L ^S *is + olJLrO C
Model 4.2
The model equation for the analytical values reduces to
where the symbols all have the same meaning as in case 1. The
assumptions (A$), (A7), (A9), and (A9') are made. Since Lj, Sj,
and ejj axe postulated as independent the variance of the analyti-
cal values is ó *
 2 = ó£ + ó| + ó|.
The following holds for all four models: The assigned value is
the total mean ÷ of all analytical values, and its uncertainty
limits are ÷ ± 2s where s is the estimation of ó j, ó2, ó3, ó^é,
ó4.2, respectively.
The following statistical test procedures were all based on an
error probability of á = 5%.
For testing (Aj), all analytical values xk were pooled. The
Anderson-Darling test due to Pettitt (7) was applied to test
their common normality.
For testing (Ai')> the values xk within each laboratory only
were pooled. The variances within laboratories were compared
with each other using the test of Levene (8).
For testing (A2), we distinguished as follows. In case 1 the
differences within series were tested for normality separately
for each laboratory using I.e. (7). In case 2 however, the first
values themselves were tested by means of I.e. (7) separately
for each laboratory.
Assumption (A$) is obviously identical to (Ai')-
For testing (A4), the ì + Lj of the model equation were
estimated by the mean of the first 15 valid series of analytical
values of each laboratory (this restriction to 15 series was
necessary here in order to avoid a systematic error in calculating
these mean values caused by different numbers of valid series
available per laboratory). These mean values were tested for
normality using again I.e. (7).
For testing (As), the error terms ejk were estimated by
xik ~ *i where Xj denotes the mean of all valid series of the
i-th laboratory. They were tested for common normality by
means of 1. c. (7).
For testing (As'), the above estimations of eik were used again.
Thus, testing for homogeneity of variances of eik or of the xik
is equivalent when using 1. c. (8).
For testing (A6) up to (A9), the first 15 valid series only of
each laboratory were used.
Testing for (A$) is identical with testing for (A4).
For testing (A7), for each serial number j the ì + Sj of the model
equation were estimated by the mean over all laboratories. These
mean values were tested for normality by use of L c. (7).
For testing (A9)jn case 1, the error term ejjk was estimated by
xijk - xij where xy = (xy, + Xjj2)/2. Because the estimations of
ejjj and ejj2 differ by their sign only we used only the independ-
ent Xjjj - x"jj in the test (7).
Assumptions (A8) in case 1 and (A9) in case 2 however could
not be tested because there are no estimations available for
(LS)jj and ejj which are "sufficiently" independent. (A90 has
not been tested, since variance estimations based on one or two
values only are impossible or without sense.
Additionally, in model 4 the analysis of variance was performed
in order to estimate the variance components ó£, ó|, ó£ä, ó|.
Conderning model 4.1 the hypothesis ó?
 ò = 0 was tested as â
described in 1. c. (6).
Results
Table 1 contains the minimal and maximal number of
valid series per laboratory and constituent after perform-
ance of the above validity checks when both values
(case 1) as well as first values only (case 2) of the double
determinations are used.
A validity check based on both values is more restrictive
than one based on first values only. That is why the
figures of case 1 partly are smaller than those of case 2.
Additionally, the table gives the total number of valid
series per constituent for both cases.
At least 15 series per laboratory and constituent are valid.
Taking exactly 15 valid series for testing (A4) and (A6)
up to (A9) is caused by this fact.
Table 2 shows the results of the statistical tests con-
cerning the assumptions in case 1.
Table 3 gives the results of the statistical tests concerning
the assumptions in case 2.
Tab. 1. Minimal and maximal number of valid series per labo-
ratory and total number per constituent.
Constituent
Creatinine
Glucose
Urea
Alanine
aminotransf erase
Aspartate
aminotransferase
Creatine kinase
•y-Glutamyl-
transferase
Case
Min.
15
15
16
15
17
16
15
la) Case 2a)
Max.
17
17
18
17
19
17
18
To-
talb)
149
146
159
179
197
150
157
Min.
16
16
17
16
17
16
15
Max.
17
18
18
17
21
17
21
To-
tal0)
152
152
161
184
199
151
160
a) Using both values (case 1) or first values only (case 2) of the
double determinations.
b) Summed up over all laboratories.
J. Clin. Chem. Clin. Biochem. / Vol. 19,1981 / No. 11
1148 Passing: The Establishment of assigned values, Part II
Tab. 2. Results of statistical tests3) using both values of double
determinations (case 1).
Assump- (Á÷) (Ai')b) (A4)c) (As) (Av) (Ag)
tiona)
Constit-
uent
Creatinine *d) * n.s.e) * n.s. *
Glucose * * n.s. * n.s. *
Urea * * n.s. * n.s. *
Alanine
aminotransferase * * n.s. * n.s. *
Aspartate
aminotransferase * * n.s. * n.s. *
Creatine kinase * * n.s. * n.s. *
7-Glutamyl-
transf erase * * n.s. * n.s. *
a) For details see materials and methods.
b) Also (A3) and (Asf).
c) Also(A6).d) Significant violation (a = 5 %) of assumption.
e) Assumption not significantly violated (a = 5%).
precision within laboratories. In fact, the standard
deviations between laboratories differed by factors 2.5
up to 8. These tests are based on at least 15 series each.
Consequently, the assumptions of model 1 are fla-
grantly violated so that it must be rejected. Therefore,
the establishment of assigned values and the calculation
of their uncertainty intervals cannot be based on the
familiar formula ÷ ± 2s.
Model 2
The results of the tests concerning (A2) are given in
table 4 which are based on at least 15 series each.
For each test performed there is theoretically a chance
of á = 5% of getting a significant result iri spite of not
being correct. Summing up over all constituents we
find 27 or 13 significances out of a total of 67. If all
significances were wrongly fourid the proportions 27/67
or 13/67 should not be statistically higher than the
above 5%. This was tested by means of 1. c. (9). Both
proportions turned out to be statistically higiher than
Tab. 3. Results of statistical testsa) using first values only of
double determinations (case 2).
Tab. 4. Results of statistical tests concerning assumption
Assump- (Áé) (AI )
tions3)
Constit-
uent
Creatinine * *
Glucose * *
Urea * *
Alanine
aminotransferase n.s. *
Aspartate
aminotransferase * *
Creatine kinase * *
7-Glutamyl-
transferase * *
b) (A4)C)
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
(A5)
n.s.
*
n.s.
n.s.
*
*
*
(A7)
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
) For details see materials and methods.
b) Also (A3) and (A5').
c) Also(A6).
Model 1
The tests are based on at least 2 · 146 = 292 values in
case 1 or 151 values in case 2. The analytical values of
all laboratories do not have a common normal distribu-
tion. This was also clear from the frequency distribution
of the data themselves because the distribution was
often skew or even not unimodal. Therefore, the assump-
tion (A!) postulating one common normal distribution
of all analytical values will be violated in general.
As to assumption (A^), the variances of analytical
values always differ significantly indicating different
Constituent
Creatinine
Glucose
Urea
Alanine aminotransferase
Aspartate aminotransferase
Creatine kinase
ã-Glutamyltransferase
Total
Labora-
tories15)
9
9
9
11
11
9
9
67
Both
values
usedc)
0
4
4
4
7
5
3
27
First
values
usedc)
0
2
1
2
4
0
4
13
a) For details see materials and methods.
b) Number of laboratories included in this study.
c) Number of laboratories thereof with distribution of analyti-
cal values deviating significantly (a = 5%) from normality.
5%. Therefore the tested values need not be distributed
normally in general. This is true for the analytical values
themselves in case 2.
In case 1 however the differences within the double
determinations were tested. They turn out not to be
distributed normally in general. It can be derived that
the analytical values are not distributed normally in
general, cf. I.e. (10).
In fact, the distribution of analytical values often looked
skew within laboratories.
From this remarkable result it can be concluded that
(A2) will be violated. The results of our method of
testing (As), based on a straightforward reasoning, con-
firm this statement.
Assumption (A3) is always statistically violated. From
the results of testing (A2) and (A3) it must be con-
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eluded that model 2 covering equal precision within
laboratories and differing accuracy is also inappropriate.
The same statement holds for the first model of I.e. (4)
and that of I.e. (5).
Model 3
No constituent shows significant deviation from nor-
mality of the ì + Lj in any case. These tests are based
on 9 up to 11 laboratories each. We tested the ì + Lj
because of independence but not the Lj themselves.
The result naturally applies to the deviations Lj of
accuracy. Therefore the distributional aspect of (A4)
formally seems not to be problematical. But basically
it is assumed that the laboratories used for evaluation
are a random sample out of the population (assumed
large) of all laboratories performing this method. In
practice however it occurs that only few reference
laboratories are available for certain methods. So, the
statistical result may be an answer to a non-realistic
question.
Assumption (A5) is very often statistically violated. The
tests are based on at least 292 or 151 values, respec-
tively. It follows that the errors eik of all laboratories
will not have a common normal distribution in general —
in spite of elimination of possible effects Lt of different
accuracy! It might be objected here that the estima-
tions of eik used are mutually dependent within labora-
tories so that the above testing procedure would not be
correct. But this mutual dependence decreases with
increasing number of values per laboratory. It should be
negligible with at least 30 or 15 values per laboratory. In
fact, most distributions of the eik turned out to be skew.
These findings assure our result concerning (A2).
Assumption (A5') is always statistically violated. There-
fore it must be concluded that model 3 covering equal
precision of laboratories and randomly differing
accuracy is inadequate. The same statement holds for
the second model in 1. c. (4).
Model 4
The results concerning (A6) and their interpretation are
identical with those of (A4).
A somewhat different consideration concerns (A7).
Indeed, we never find a significant deviation from
normality of the ì + Sj in any case based on 15 series
each. We conclude that the random deviations Sj can
have a normal distribution. The series performed are
assumed as a random sample out of the large popula-
tion of all series which are imaginable or might be per-
formed. This postulate does not make sense because
series are produced consecutively and not on a random
basis. However, it ensures that analytical values of
different series will be "more independent" than values
of multiple determinations of the same series.
Assumption (A9) in case 1 is always statistically violated.
Each test is based on at least 135 values. So the analyti-.
cal errors Cjjk within series of all laboratories and all
series will not have a common normal distribution in
general — in spite of elimination of possible effects of
different accuracy between series. In fact, most distribu-
tions of analytical errors were skew.
The model seems acceptable statistically in case 2 but
not in case 1. This contradiction is clarified by the
following arguments. First, assumption (A9) could not
be tested in case 2. Furthermore, the absence of addi-
tivity of laboratorial and serial effects will be shown in
both cases by using further mathematical arguments.
Since the model equation of case 2 does not cover this
possibility model 4.2 is inappropriate. Indeed, in case 1
the model equation does cover this possibility by means
of the interaction term. But since assumption (A9) is
violated in case 1 it can be summarized: Models 4.1
and 4.2 must be refused. They cover equal precision
within series and randomly differing accuracy between
laboratories and series.
In detail, some variance components which are clearly
expected to be positive are given in table 5.
Tab. 5. Some results of the analysis of variance of model 4a).
Constituent Signs ) of 55 F-value
for inter-
Caselc) Case2c) action
Creatinine
Glucose
Urea
Alanine aminotransferase
Aspartate aminotransferase
Creatine kinase
T-Glutamyltransferase
>0
>0
>0
>0
>0
>0
>0
<0
>0
<0
<0
<0
<0
<0
12.4
3.8
2.2
2.9
5.3
2.8
3.7
a) For details see materials and methods.
b) s| is the estimation of ó|
c) Using both values (case 1) or first values only (case 2) of the
double determinations.
In case 2 most estimations s| of ó| are negative whereas
SL was always positive. In case 1 however, all s| and all
other variance components are positive. This is not
caused by certain distributional assumptions being
violated because it is a numerical and not a statistical
effect. The reason is that the assumption of additivity
of laboratorial and serial effects in the model equation
cannot be correct in case 2. Unfortunately it is im-
possible to modify this assumption by enlarging the
model in case 2. In case 1 however, non-additivity is
explicitly contained in the model equation by means of
the interaction term which causes all variance compo-
nents to be positive.
The importance of this interaction term is stressed by
the fact that the F-value for testing the hypothesis
°LS = 0» ß·e· 16 absence of any interaction in case 1, is
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always higher (cf. table 5) than a "critical value" of
approximately 1.35. So interactions are "significantly"
present, cf. 1. c. (6). But this conclusion would be cor-
rect only if all model assumptions were fulfilled — in
contrast to our result. Therefore it is necessary to avoid
the notion of significance here and to state only qualita-
tively: The F-values found are much higher than 1.35 so
that the existence of interactions is shown with high
probability. s| was often found negative but never s£.
The reason is that for each constituent s£ was much
larger than the absolute value of s|. Therefore s£
was less sensitive to become negative than s|. This
reflects the well known fact that the variance between
laboratories usually is larger than between series.
Discussion
The assumptions of all four models can be divided into
two classes:
Assumptions (A4), (A6), (A7), and (A8) concern prop-
erties of effects admitted by the respective model.
Partly they restrict the applicability of the models from
practical considerations.
The other assumptions however concerning the distribu-
tion of errors imply that these errors are symmetrically
distributed. Actually we found most distributions skew,
especiaDy the distribution of analytical errors within
series (model 4). From this the skewness of the error
distributions of models 1 and 3 found when examining
(Aj) and (A5) can be clarified: It cannot completely be
explained by deviation of single laboratories or even
series which are not covered by the respective model.
Furthermore, our results confirm the well known fact
that precision differs between laboratories.
Now we must stress the consequences of a violation of
assumptions.
In case of a skew error distribution it is no longer mean-
ingful to give ÷ as assigned value because many cus-
tomers expect that approximately 50% of their analyti-
cal values are on each side of the given assigned value.
They would then be falsely irritated or call in question
the accuracy of the assigned value if they did not find
this to be the case. In the case of symmetry however
this problem cannot arise, since the mean value x" and
median are then approximately identical. But by giving
the symmetrical uncertainty limits ÷ ± 2s with s of the
respective model the customer is misled into believing
that symmetry exists. Therefore, skew uncertainty limits
should be given in case of skew distributions in. order to
assist the customer rather than to confuse him.
There is still another serious statistical argument. Every-
body believes that with 95% probability a further
analytical value is expected to be within the uncertainty
interval given if systematic deviations do not occur.
This statistical statement however depends essentially on
all assumptions being met. For instance, it would not
suffice to have symmetry, but the stricter assumption
of normality must be fulfilled. Conversely, nobody is ,
able to assess the correct probability level if the assump-
tions are violated. In fact, it can be much less than 95%.
Indeed, we have analysed only certain constituents. But
therefrom we can derive that assumptions of models 1
up to 4 can be violated in practice. Similar results are
giveninl.cf(3).
Apart from these results concerning distributions there
is another fault of models 2, 3, and 4. Their model
equations include differences of accuracy between the
reference laboratories which is supported by our results.
At the moment of establishing assigned values this
possibility is taken into consideration by ijieans of the
respective variance estimation, which only results in
different widths of the respective uncertainty intervals.
Generally, the intervals of models 2, 3, or 4 are smaller
than those given by model 1 where differences of
accuracy are neglected. However, the assigned value it-
self is an estimation of the general mean ì, and so the
uncertainty limits give a prediction interval for a
further analytical value distributed around ì. The widths
of these intervals do not include any differences of
accuracy.
Yet, at the moment when a customer applies this con-
trol serum as internal quality control it must be con-
ceded that his accuracy may differ from ì because
models 2, 3, and 4 admit different accuracy even for the
reference laboratories. In fact, its accuracy might be
ì + 1 for a certain deviation / of accuracy so that ana-
lytical values are distributed around ì + /. Then the
given uncertainty limits are misleading. Rather, this
laboratory would need uncertainty limits around ì + /.
More precisely, for each laboratory using this control
serum special limits fitted to the respective ì + / would
be necessary.
This is completely impossible, firstly from practical con-
siderations, and secondly because the individual ì + /
cannot be known in advance. Consequently, from this
point of view models 2 up to 4 are inappropriate.
Therefore, other models should be defined in order to
have a strategy for the evaluation of assigned values and
their uncertainty limits which is applicable to all con-
stituents and which is always correct. Such models do
exist.
All models based on an analysis of variance and so using
x"and some kind of s need assumptions concerning
normality and equal precision. Necessarily they cover
differences of accuracy of the reference laboratories
only. Therefore this complete class of models will be
inadequate. The difficulties described can be avoided
by using distribution-free techniques. In part 3 of this
series (11) we compare three distribution^free
dures.
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consequences from the results were drawn jointly by all partici-
pants.
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